Literature DB >> 7105494

Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.

R M Uibo, H J Helin, K J Krohn.   

Abstract

Humoral and cellular immunity to a liver-specific membrane lipoprotein (LSP) was followed in rabbits immunized either with allogenic rabbit LSP (RLSP) or with xenogenic human (HLSP) or bovine (BLSP) antigens. After 4 months of immunization, all rabbits showed histological changes in liver resembling those found in chronic aggressive hepatitis and occasionally also those seen in primary biliary cirrhosis in man. Antibodies reacting to both allogenic as well as xenogenic LSP preparations were found with an enzyme-linked solid phase immunosorbent assay (ELISA) in all immunized rabbits. Lymphocyte transformation tests in unimmunized rabbits showed an occasional response to some of the LSP preparations and a strong response towards an equivalent rabbit kidney preparation (RKSP). After immunization, reactions to LSP preparations increased significantly, while no response to RKSP was observed. The results confirm previous findings and further demonstrate that similar LSP containing preparations from human, bovine and rabbit sources share autoantigenic, liver-specific determinants. In addition, species specific determinants seem to be present in each of the LSP preparations studied.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105494      PMCID: PMC1536450     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Autoimmunity in chronic active hepatitis and diabetes mellitus.

Authors:  R M Galbraith; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1977-07

2.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

4.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

5.  Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.

Authors:  A Uotila; K M Marnela; A Hamblin; K Krohn
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

6.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

7.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

8.  Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.

Authors:  S Kakumu; Y Arakawa; H Goji; T Kashio; K Yata
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

9.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

10.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

View more
  9 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.

Authors:  Y Watanabe; H Kawakami; H Kawamoto; Y Ikemoto; K Masuda; E Takezaki; T Nakanishi; G Kajiyama; H Takeno
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M McFarlane; G N Major; P Tolley; R Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

4.  Immunohistochemical localization of human liver specific protein using rabbit antisera and the avidin-biotin complex technique.

Authors:  H Helin; R Uibo; I Paronen; K Krohn
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Inhibition of autoimmune hepatitis with hot labelled liver specific antigen.

Authors:  J Fehér; G Filipp; L Kocsár; K Mohari; H Toncsev; E Fehér; G Biro
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

6.  Adoptive transfer of experimental autoimmune hepatitis in mice--cellular interaction between donor and recipient mice.

Authors:  M Ogawa; Y Mori; T Mori; S Ueda; H Yoshida; I Kato; K Iesato; Y Wakashin; R Azemoto; M Wakashin
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

7.  Studies on experimental chronic active hepatitis in the rabbit. II. Immunological findings.

Authors:  R C Butler
Journal:  Br J Exp Pathol       Date:  1984-08

8.  Studies on experimental chronic active hepatitis in the rabbit. I. Induction of the disease by immunization with muscle as well as liver proteins.

Authors:  R C Butler
Journal:  Br J Exp Pathol       Date:  1984-08

9.  Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.

Authors:  Y Mori; T Mori; S Ueda; H Yoshida; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.